Phase Ib study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	354-354
Number of pages	1
Journal	Annals of Oncology
Volume	29
Issue number	Suppl_8
DOIs	https://doi.org/10.1093/annonc/mdy285.199
Publication status	Published - Oct-2018
Event	43rd ESMO Congress (ESMO) - Munich, Germany Duration: 19-Oct-2018 → 23-Oct-2018

Access to Document

Phase Ib study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with
Final publisher's version, 76.3 KB

@article{60cdc79e9d1d4545a969ff064cfd1997,

title = "Phase Ib study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer",

author = "Broekman, {K. E.} and Reyners, {A. K. L.} and Touw, {D. J.} and Hof, {M. A. J.} and M. Jalving",

year = "2018",

month = oct,

doi = "10.1093/annonc/mdy285.199",

language = "English",

volume = "29",

pages = "354--354",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl_8",

note = "43rd ESMO Congress (ESMO) ; Conference date: 19-10-2018 Through 23-10-2018",

}

TY - JOUR

T1 - Phase Ib study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer

AU - Broekman, K. E.

AU - Reyners, A. K. L.

AU - Touw, D. J.

AU - Hof, M. A. J.

AU - Jalving, M.

PY - 2018/10

Y1 - 2018/10

U2 - 10.1093/annonc/mdy285.199

DO - 10.1093/annonc/mdy285.199

M3 - Meeting Abstract

VL - 29

SP - 354

EP - 354

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - Suppl_8

T2 - 43rd ESMO Congress (ESMO)

Y2 - 19 October 2018 through 23 October 2018

ER -